Global Plan to end TB 2016-2020
Why a 4°C warmer world must be avoided
J Epidemiol Infect Dis 1(1): 00003.n DOI: 10.15406/jeid.2017.01.00003
Published: September 14, 2017
Working with limited resources in armed conflict and other situations of violence. Vol.1
UNAIDS and DPKO non paper | 2011
Research Article
Received: August 21, 2017; Accepted: August 29, 2017; Published: Spetember 05,
2017
This article is available in: http://www.imedpub.com/advanced-techniques-in-clinical-microbiology/
Guidance | Preparedness - Response and early recovery - Recovery and reconstruction
DEVELOPMENT BULLETIN | No.74, June 2011 | Editor: Pamela Thomas | Features and case studies | Progress with implementing conventions and strategies | Progress with capacity building | Progress with disability-inclusive education | Disability-inclusive research | Innovative inclusion | Review of urba...nisation in the Pacific | Development assistance and disability
more
AIDSTAR-One | CASE STUDY SERIES November 2012
This report found that many people with disabilities enter institutions as children and remain there for their entire lives. Most of these institutions visited by Human Rights Watch researchers did not provide for more than people’s basic needs, such as food and hygiene, with scarce contact with t...he community and little opportunity for personal development. Some residents are tied to their beds and given sedatives to control them.
more
Guidance | Preparedness - Response and early recovery - Recovery and reconstruction
A new report released today documents an “invisible wall” which has blocked migrants from accessing basic services since the start of the COVID-19 pandemic, and is now preventing them from accessing vaccines.
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
more